Expression of growth hormone in canine mammary tissue and mammary tumors: Evidence for a potential autocrine/paracrine stimulatory loop

American Journal of Pathology

Volumn 150, Issue 3, 1997, Pages 1037-1047

  Van Garderen, Evert ^a   De Wit, Moniek ^a   Voorhout, Wim F ^a   Rutteman, Gerard R ^a   Mol, Jan A ^a   Nederbragt, Hubertus ^a   Misdorp, Wim ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GESTAGEN; GROWTH HORMONE; PROGESTERONE; PROGESTERONE RECEPTOR;

ANESTRUS; ANIMAL TISSUE; ARTICLE; BREAST; BREAST CARCINOGENESIS; BREAST EPITHELIUM; BREAST TUMOR; DOG; GENE EXPRESSION; HORMONE SYNTHESIS; IMMUNOELECTRON MICROSCOPY; LUTEAL PHASE; MALIGNANT TRANSFORMATION; NONHUMAN; OVARY CYCLE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SECRETORY GRANULE;

ANIMALS; DOGS; EPITHELIUM; ESTRUS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GROWTH HORMONE; HYPERPLASIA; IN SITU HYBRIDIZATION; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, ANIMAL; MICROSCOPY, IMMUNOELECTRON; PROGESTERONE;

EID: 0031049823     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Rillema JA: Development of the mammary gland and lactation. Trends Endocrinol Metab 1994, 5:149-154
2. Fernig DG, Smith JA, Rudland PS: Relationship of growth factors and differentiation in normal and neoplastic development of the mammary gland. Cancer Treat Res 1991, 53:47-78
3. Cullen KJ, Allison A, Martire I, Ellis M, Singer C: Insulin-like growth factor expression in breast cancer epithelium and stroma. Breast Cancer Res Treat 1992, 22:21-29
4. Cullen KJ, Smith HS, Hill S, Rosen N, Lippman ME: Growth factor messenger RNA expression by human breast fibroblasts from benign and malignant lesions. Cancer Res 1991, 51:4978-4985
5. McAndrew J, Fernig DG, Rudland PS, Smith JA: Secretion of transforming growth factor-α and expression of its receptor in human mammary cell lines. Growth Factors 1994, 10:281-287
6. Bacus SS, Zelnick CR, Plowman G, Yarden Y: Expression of the erbB-2 family of growth factor receptors and their ligands in breast cancers: implication for tumor biology and clinical behavior. Am J Clin Pathol 1994, 102:S13-S24
7. Pierce DF, Gorska AE, Chytil A, Meise KS, Page DL, Coffey RJ, Moses HL: Mammary tumor suppression by transforming growth factor-β1 transgene expression. Proc Natl Acad Sci USA 1995, 92:4254-4258
8. Pike MC, Spicer DV, Dahmoush L, Press MF: Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev 1993, 15:17-35
9. King RJB: Biology of female sex hormone action in relation to contraceptive agents and neoplasia. Contraception 1991, 43:527-542
10. Horwitz KB: The molecular biology of RU486. Is there a role for antiprogestins in the treatment of breast cancer? Endocr Rev 1991, 13:146-162
11. van Leeuwen FE: Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer. Acta Endocrinol (Copenh) 1991, 125:13-26
12. Pike MC, Henderson BE, Krailo MD, Duke A, Roy S: Breast cancer in young women and use of oral contraceptives: possibly modifying effect of formulation and age at use. Lancet 1983, 2:926-930
13. Pike MC, Henderson BE, Casagrande JT, Rosario I, Gray GE: Oral contraceptive use and early abortion as risk factors for breast cancer in young women. Br J Cancer 1981, 43:72-76